Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2701 AL 2715

Cognitive and Psychiatric Adverse Effects of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease

Brohée S, Roze E, Grabli D, Letrillart H, Mantisi L, Foucard C, Hainque E, Cormier F, Méneret A, Hauw F.

Mov Disord Clin Pract. 2025 Jul;12(7):1028-1030. doi: 10.1002/mdc3.70060. Epub 2025 Mar 28.

Managing impulse control and related behavioral disorders in Parkinson's disease: where we are in 2025?

Rigon L, Fogliano C, Chaudhuri KR, Poplawska-Domaszewicz K, Falup-Pecurariu C, Murasan I, Wolfschlag M, Odin P, Antonini A.

Expert Rev Neurother. 2025 May;25(5):537-554. doi: 10.1080/14737175.2025.2485337. Epub 2025 Apr 2.

The Role of Machine Learning in Cognitive Impairment in Parkinson Disease: Systematic Review and Meta-Analysis

Wu Y, Cheng Y, Xiao Y, Shang H, Ou R.

J Med Internet Res. 2025 Mar 14;27:e59649. doi: 10.2196/59649.

Common and specific effects in brain oscillations and motor symptoms of tDCS and tACS in Parkinson's disease

Liu J, Zhu Y, Chen B, Meng Q, Hu P, Chen X, Bu J.

Cell Rep Med. 2025 Apr 15;6(4):102044. doi: 10.1016/j.xcrm.2025.102044. Epub 2025 Mar 27.

Using Single-Cell RNA sequencing with Drosophila, Zebrafish, and mouse models for studying Alzheimer's and Parkinson's disease

Lau F, Binacchi R, Brugnara S, Cumplido-Mayoral A, Savino SD, Khan I, Orso A, Sartori S, Bellosta P, Carl M, Poggi L, Provenzano G.

Neuroscience. 2025 May 7;573:505-517. doi: 10.1016/j.neuroscience.2025.03.042. Epub 2025 Mar 26.

Multimodal diagnostic tools and advanced data models for detection of prodromal Parkinson's disease: a scoping review

Serag I, Azzam AY, Hassan AK, Diab RA, Diab M, Hefnawy MT, Ali MA, Negida A.

BMC Med Imaging. 2025 Mar 28;25(1):103. doi: 10.1186/s12880-025-01620-5.

Deep Brain Stimulation Improves Symptoms in an Individual with Alpha-Synuclein-Gene-Associated Parkinson's Disease

Braun A, Basson D, Moosa S, Carr J, Bardien S, van Coller R.

Mov Disord Clin Pract. 2025 Aug;12(8):1200-1203. doi: 10.1002/mdc3.70057. Epub 2025 Mar 29.

Multidimensional mechanisms of anxiety and depression in Parkinson's disease: Integrating neuroimaging, neurocircuits, and molecular pathways

Zhao J, Jia H, Ma P, Zhu D, Fang Y.

Pharmacol Res. 2025 May;215:107717. doi: 10.1016/j.phrs.2025.107717. Epub 2025 Mar 28.

Application of curcuminoids in inflammatory, neurodegenerative and aging conditions - Pharmacological potential and bioengineering approaches to improve efficiency

Lagoa R, Rajan L, Violante C, Babiaka SB, Marques-da-Silva D, Kapoor B, Reis F, Atanasov AG.

Biotechnol Adv. 2025 Sep;82:108568. doi: 10.1016/j.biotechadv.2025.108568. Epub 2025 Mar 27.

α-Synuclein pathology and mitochondrial dysfunction: Toxic partners in Parkinson's disease

Mingo YB, Escobar Galvis ML, Henderson MX.

Neurobiol Dis. 2025 Jun 1;209:106889. doi: 10.1016/j.nbd.2025.106889. Epub 2025 Mar 27.

Mitochondrial DNA copy number and Alzheimer's disease and Parkinson disease

Qin P, Chen X, Ma P, Li X, Lin Y, Liu X, Liang X, Qin T, Liang J, Ouyang J.

Mitochondrion. 2025 Jul;83:102032. doi: 10.1016/j.mito.2025.102032. Epub 2025 Mar 27.

Authors' reply to "Comment on Chaparro-Solano et al.: 'Critical evaluation of the current landscape of pharmacogenomics in Parkinson's disease - What is missing? A systematic review'"

Chaparro-Solano HM, Mata IF.

Parkinsonism Relat Disord. 2025 May;134:107804. doi: 10.1016/j.parkreldis.2025.107804. Epub 2025 Mar 20.

Gut microbiota and microRNAs as biomarkers in Parkinson's disease: early identification, diagnostic and potential treatments

Hernández-García J, Muro-Reche P, Orenes-Piñero E.

Mol Cell Biochem. 2025 Aug;480(8):4573-4586. doi: 10.1007/s11010-025-05271-6. Epub 2025 Mar 31.

Redox modulatory role of DJ-1 in Parkinson's disease

Alshammari QA.

Biogerontology. 2025 Mar 30;26(2):81. doi: 10.1007/s10522-025-10227-w.

Exergame-Based Program and Conventional Physiotherapy Based on Core Areas of the European Guideline Similarly Improve Gait and Cognition in People with Parkinson's Disease: Randomized Clinical Trial

Nuvolini RA, Silva KGD, Freitas TB, Doná F, Torriani-Pasin C, Pompeu JE.

Games Health J. 2025 Oct;14(5):358-368. doi: 10.1089/g4h.2024.0116. Epub 2025 Mar 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias